Maxim Group analyst Michael Okunewitch has maintained their bullish stance on LCTX stock, giving a Buy rating on January 3.Stay Ahead of the ...

Offers Comprehensive Resource to Help Small Business Owners Save Money and Avoid Common Tax Pitfalls IRVINE, CA / ACCESSWIRE ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

Morgan Stanley likes financials, energy, real estate, and domestically-focused materials and consumer-goods companies.